Onderneming Ocugen, Inc. Börse Stuttgart
Aandelen
2H51
US67577C1053
Biotechnologie & Medisch Onderzoek
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,69 EUR | -4,09% |
|
+7,50% | +220,95% |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Shankar Musunuri
CEO | Chief Executive Officer | 60 | 01-01-13 |
Director of Finance/CFO | 42 | - | |
Jesse Simmers
CTO | Chief Tech/Sci/R&D Officer | - | - |
Huma Qamar
CTO | Chief Tech/Sci/R&D Officer | - | - |
Nirdosh Jagota
CMP | Compliance Officer | - | - |
Arun Upadhyay
CTO | Chief Tech/Sci/R&D Officer | - | 01-02-17 |
J.P. Gabriel
PRN | Corporate Officer/Principal | - | - |
Michael Shine
PRN | Corporate Officer/Principal | - | 10-06-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 76 | 17-03-22 | |
Director/Board Member | 74 | 05-04-20 | |
Shankar Musunuri
CEO | Chief Executive Officer | 60 | 01-01-13 |
Uday Kompella
FOU | Founder | 57 | 01-01-13 |
Junge Zhang
BRD | Director/Board Member | 57 | 01-09-19 |
Kirsten Castillo
BRD | Director/Board Member | 51 | 05-04-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 257 475 966 | 253 282 714 ( 98,37 %) | 121 500 ( 0,0472 %) | 98,37 % |
Aandeel B | 0 | 54 745 | 0 | 0 |
Bedrijfsgegevens
![Adres Ocugen, Inc.(2H51)](https://cdn.zonebourse.com/static/address/50919212.png)
Sector
![Consensus](/images/consensus_flch.gif)
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+25,83% | 47,96 mld. | |
+44,76% | 41,47 mld. | |
+0,69% | 42,45 mld. | |
+30,52% | 31,6 mld. | |
+22,30% | 28,63 mld. | |
-6,35% | 28,03 mld. | |
+49,25% | 14,56 mld. | |
+49,18% | 14,14 mld. | |
+3,45% | 12,58 mld. |
- Beurs
- Aandelen
- Koers OCGN
- Koers 2H51
- Onderneming Ocugen, Inc.